Market Access & HEOR Consulting
All Organisations
Analysis Group, Inc.
US-based economic consulting firm with published outcomes and cost-effectiveness analyses on esketamine treatment pathways relevant to payer decision-making and market access strategy.
Charles River Associates
Economic and strategy consultancy with life sciences advisory services, including published analysis on the evolving psychedelic therapeutics landscape and market implications.
Delphi Circle
Psychedelic-focused strategy and reimbursement advisory organization with explicit work on market access and reimbursement pathways, including Europe-focused analyses.
IQVIA Real World Data
Commercial real-world data products and linked evidence assets used in life sciences research and regulatory support.
L.E.K. Consulting
Global strategy consultancy with US/EU healthcare practices and published analysis on psychedelic treatment pathways, funding dynamics, and commercialization implications.
Lumanity
Global commercialization and market access advisory firm with published commentary on positioning psychedelic medicines within biopharmaceutical development frameworks.